Insights

Innovative Product Pipeline SOMAÍ is developing a robust pipeline of cannabis-based therapeutics, including EU-GMP full-spectrum extracts formulated from single strains, positioning it as a leader in pharmaceutical-grade cannabis products suitable for medical markets.

Strategic Partnerships Recent collaborations with entities like Sherbinskis and Canymed GmbH indicate opportunities to expand distribution channels and enter new healthcare and pharmacy networks across Europe and Germany, opening doors for medical product sales.

Market Expansion With a focus on global footprint growth and acquisitions such as RPK Biopharma, SOMAÍ is actively increasing its market presence in diverse regions, offering sales opportunities in emerging and established medical cannabis markets.

Operational Capabilities Owning state-of-the-art manufacturing and indoor cultivation facilities in Lisbon enables SOMAÍ to supply high-quality, pharmaceutical-grade products reliably, making it an attractive partner for healthcare providers and distributors seeking consistent supply.

Financial Momentum Backed by $10M in funding and a strategic focus on mergers and acquisitions, SOMAÍ is well-positioned for growth and scaling its sales efforts in Europe, particularly within the medical and pharmaceutical sectors with increasing acceptance of cannabis-based medicines.

SOMAÍ Tech Stack

SOMAÍ uses 8 technology products and services including Tilda, WooCommerce, Mailchimp, and more. Explore SOMAÍ's tech stack below.

  • Tilda
    Content Management System
  • WooCommerce
    E-commerce
  • Mailchimp
    Email
  • Google Fonts API
    Font Scripts
  • Mapbox GL JS
    Maps
  • Microsoft
    Miscellaneous
  • Gravity Forms
    Web Platform Extensions
  • Apache
    Web Servers

Media & News

SOMAÍ's Email Address Formats

SOMAÍ uses at least 1 format(s):
SOMAÍ Email FormatsExamplePercentage
FL@somaipharma.euJD@somaipharma.eu
48%
LF@somaipharma.euDJ@somaipharma.eu
3%
First.Last@somaipharma.euJohn.Doe@somaipharma.eu
1%
FL@somaipharma.euJD@somaipharma.eu
48%

Frequently Asked Questions

Where is SOMAÍ's headquarters located?

Minus sign iconPlus sign icon
SOMAÍ's main headquarters is located at Lisbon, PT. The company has employees across 5 continents, including EuropeOceaniaSouth America.

What is SOMAÍ's official website and social media links?

Minus sign iconPlus sign icon
SOMAÍ's official website is somaipharma.eu and has social profiles on LinkedInCrunchbase.

What is SOMAÍ's NAICS code?

Minus sign iconPlus sign icon
SOMAÍ's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SOMAÍ have currently?

Minus sign iconPlus sign icon
As of October 2025, SOMAÍ has approximately 60 employees across 5 continents, including EuropeOceaniaSouth America. Key team members include Head Of Medical Sales: F. R.Founder, Interim Chairman And Ceo: M. S.Co-Founder Somai Pharmaceuticals: G. B.. Explore SOMAÍ's employee directory with LeadIQ.

What industry does SOMAÍ belong to?

Minus sign iconPlus sign icon
SOMAÍ operates in the Pharmaceutical Manufacturing industry.

What technology does SOMAÍ use?

Minus sign iconPlus sign icon
SOMAÍ's tech stack includes TildaWooCommerceMailchimpGoogle Fonts APIMapbox GL JSMicrosoftGravity FormsApache.

What is SOMAÍ's email format?

Minus sign iconPlus sign icon
SOMAÍ's email format typically follows the pattern of FL@somaipharma.eu. Find more SOMAÍ email formats with LeadIQ.

How much funding has SOMAÍ raised to date?

Minus sign iconPlus sign icon
As of October 2025, SOMAÍ has raised $10M in funding. The last funding round occurred on Jul 15, 2024 for $10M.

When was SOMAÍ founded?

Minus sign iconPlus sign icon
SOMAÍ was founded in 2019.

SOMAÍ

Pharmaceutical ManufacturingLisbon, Portugal51-200 Employees

SOMAÍ is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio.

At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.

SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.

Section iconCompany Overview

Headquarters
Lisbon, PT
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $10M

    SOMAÍ has raised a total of $10M of funding over 5 rounds. Their latest funding round was raised on Jul 15, 2024 in the amount of $10M.

  • $1M$10M

    SOMAÍ's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $10M

    SOMAÍ has raised a total of $10M of funding over 5 rounds. Their latest funding round was raised on Jul 15, 2024 in the amount of $10M.

  • $1M$10M

    SOMAÍ's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.